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Summary
Objective: This project audited rate and extent of 
weight loss in a primary care/commercial weight man-
agement organisation partnership scheme. Methods: 
34,271 patients were referred to Slimming World for 
12 weekly sessions. Data were analysed using individ-
ual weekly weight records. Results: Average (SD) BMI 
change was –1.5 kg/m2 (1.3), weight change –4.0 kg 
(3.7), percent weight change –4.0% (3.6), rate of weight 
change –0.3 kg/week, and number of sessions attended 
8.9 (3.6) of 12. For patients attending at least 10 of 
12 sessions (n = 19,907 or 58.1%), average (SD) BMI 
change was –2.0 kg/m2 (1.3), weight change –5.5 kg 
(3.8), percent weight change –5.5% (3.5), rate of weight 
change –0.4 kg/week, and average number of sessions 
attended was 11.5 (0.7) (p < 0.001, compared to all pa-
tients). Weight loss was greater in men (n = 3,651) than 
in women (n = 30,620) (p < 0.001). 35.8% of all patients 
enrolled and 54.7% in patients attending 10 or more 
sessions achieved at least 5% weight loss. Weight gain 
was prevented in 92.1% of all patients referred. At-
tendance explained 29.6% and percent weight lost in 
week 1 explained 18.4% of the variance in weight loss. 
Conclusions: Referral to a commercial organisation is 
a practical option for National Health Service (NHS) 
weight management strategies, which achieves clini-
cally safe and effective weight loss.
Introduction





[4]. Recent Foresight predictions suggest that if current

















highlights the complexity of the obesity problem [1].How-
ever,manytherapistshaveemphasisedthatwhilemuchofthe
causeofobesityisduetoacomplexinterplaybetweengenetic







in their obesity guidance, the UK National Institute for
HealthandClinicalExcellence(NICE)recognisestheimpor-
tance of providing regular and ongoing support for behav-




cross-departmental government report ‘Healthy Weight,
HealthyLives’ recognised thevital roleplayedby the com-
mercial sector and other providers in ensuring that more
peoplecanaccesseffectiveservicesinordertoincreasecost-
effectiveprovisionofhealthservicecapacity[13].











Since the feasibility study, the referral scheme has been
offerednationallytoNHSTrustsandenablesequalaccessto




freeparticipation for 12weeks topatients referredby their











carepathways.All areas incorporated in this analysis excludedpatients
under 16 years and pregnantwomen.At the point of referral, patients
were issueda12-weekvoucherpacktobecompleted in thespaceof14








criteria to help adults develop the lifestyle changes needed to reduce
weight,preventweightgain,andsupportlong-termweightmaintenance.








patients who were referred from within 77 PCTs or NHS Trusts, for
whomdata onweight, height, age, and genderwere collected.Among
thesewere2,625caseswherethedataforoneormoreofthe12referral




in thepresent audit. 80participantswere included in thedatabasebut
therewasnodatafortheirdateofbirth.Agedataarereportedexcluding
thesesubjects.Someoftheparticipantswentontoself-fundfurtherat-
tendance following the initial 12-week referralandotherswereoffered
subsequent12-weekreferralpackagesfromtheirhealthcareteam(9,852







ral), their startweight anddatewere recorded.Eachweek thepatient




Thiswork is categorised as a service evaluation under theAdHoc
AdvisoryGroupontheOperationofNHSResearchEthicsCommittees
guidelines (2006). Existing data were anonymised and analysed as an
intervention in use only to ask the question ‘What standard does this
serviceachieve?’.
Data Analysis
Data were extracted from the referral database and subjected to a
numberofparameterchecksforoutliersaswellasanomalousdataentry.
Anomalieswerecheckedagainsttherawsourcedatatoresolveanyissues
that arose. From the raw data collected, start BMI, end BMI, BMI
change,weightchange,andpercentweightchangewerecalculated.The
end weight was calculated based on the members’ last attendance at
group during the referral period using the Last Observation Carried
Forward approach [15]. Patientswere classified as ‘completers’ if they






of factors were tested by Pearson’s Chi-square tests. Associations be-
tweenweightlossesindifferentweekswereexaminedbyPearson’scor-
relationcoefficients.AllanalysiswasperformedusingtheGENSTAT5








of thewholepopulation lostequal toormore than10%of
theirbodyweightoverthe12sessions.Inthepresentaudit,
92.1%ofallparticipantslostweightorremainedweightsta-





p < 0.001) during the 12-session referral period. The same
patternswereevidentforpercentweightloss(–5.5vs.–1.8%,
respectively;t=99.94;p<0.001).Thus,whilecompletersand
non-completersdidnotdiffersignificantly in termsof initial
height or much in weight or BMI, the completers lost a
greaterweight,percentweight, andhadagreater change in
BMI (table 1). Non-completers were on average 4.8 years
youngerthancompleters(t=–28.12;p<0.001).
Figure1showsthepercentageofcompletersandnon-com-




10%of their initial bodyweight by the end of the referral
period(p < 0.001).
Men and Women
Table 2 compares the characteristics and weight loss out-
comes for men and women. Men were on average taller,




attend toagreaterdegree thanwomen, theyhadagreater
BMIchangethanwomenfor the12sessionsof thereferral
scheme(p<0.001).Therewas,however,asignificantdiffer-
ence in thepercentageofmenandwomenclassedas com-





Characteristics of the 34,271 subjects (3,651 men; 30,620
women)wereasfollows:Themean(SD)agewas47.3(14.4)
years, height 1.65m (0.09), andweightwas99.4kg (20.0).
Mean start BMI was 36.8 kg/m2 (6.5) and 25.4% of the
referredpopulationhadastartingBMIinexcessof40kg/m2.
Weight Change and Attendance
Mean (SD) weight change of all participants was –4.0 kg
(3.7), percent weight change was –4.0 (3.6), end BMI was
35.3kg/m2(6.4),andmeanBMIchangewas–1.5kg/m2(1.3).
Average (SD) attendance was 8.9 (3.6) sessions. 19,907
(58.1%)ofthepatientsattendedatleast10ofthe12sessions
(completers) and14,364 (41.9%)were classedasnon-com-
pleters(i.e.thosewhoattendedfewerthan10ofthe12ses-
sions).Thecharacteristicsandoutcomesforcompletersand
non-completers are given in table 1.Average (SD) attend-
anceof completerswas11.5 (0.7) sessionsand thatofnon-
completerswas5.3(2.6)sessions.35.8%ofthewholepopu-
Completers,n=19,907 Non-completers,n=14,364 t-value p-value
average SD average SD
Height,m  1.65  0.09  1.65  0.09 –1.46 0.144
Weight,kg 99.7 20.1 99.0 19.8 –5.32 <0.001
Age,years 49.3 14.4 44.5 14.1 –28.12 <0.001
Weightchange,kg –5.5  3.8 –1.8  2.3 95.09 <0.001
Percentweightchange –5.5  3.5 –1.8  2.3 99.94 <0.001
Weeksattended 11.5  0.7  5.3  2.6 –292.13 <0.001
StartBMI,kg/m2 36.9  6.5 36.6  6.5 –5.05 <0.001
EndBMI,kg/m2 34.9  6.3 36.0  6.4 12.75 <0.001


















Fig. 1. Percent of completers and non-completers achieving less than
5%,between5–10%, and>10%weight loss by the endof the referral
scheme(n=34,271).
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clear that the greatest predictor of percentweight losswas
the number of attendances (table 4). On averagemen lost
moreweightthanwomenoverthereferralperiod(t=–11.61;
p < 0.001). For every unit increase in start BMI subjects
tendedtoloseanadditional0.01%weightbytheendofthe
referral period (t = 3.92; p < 0.001). Age, but not height,
significantlypredictedpercentweight lostby theendof the
referralperiod;aswithBMI theeffectwas small (t=–6.12;
p<0.001).Table4showstheaccumulatedANOVAforthe
predictorsofweight loss, giving the factors,percentofvari-
ance explained, F-ratios, and probability statistics formain
effects. It is clear from table4 thatage,height,gender,and
startingBMIall explainedavery small amountof thevari-
anceinpercentweightlost.Attendanceaccountedfor29.6%
ofthetotalvarianceinpercentweight lostattheendofthe
referralperiod.Percentweight lostduring the firstweekof




lossover the 12 sessionsof the scheme for thewhole audit




period were percent weight lost in the first week and at-
tendancethroughoutthe12weeklysessions.However,week






Rates of Weight Loss
Theaveragerateofweight lossoverthe12sessions(when




Completers lost weight at a significantly faster rate than
did non-completers (0.4 vs. 0.1 kg/week). These patterns
werealsoapparentforpercentweightloss(bothp<0.001).
Analysing only subjects who completed within a 12-week
timewindow increased theslope for rateofweight lossby







losswas not significantly different between completers and
non-completers.
Prediction of Weight Loss
Table 3 gives the regression coefficients for percentweight
lossattheendofthereferralperiodforage,height,gender,
startingBMI,attendances,andpercentweightlostinthefirst
week, together with t-statistics and probability values. It is
Men,n=3,651 Women,n=30,620 t-value p-value
average SD average SD
Height,m   1.77  0.08  1.63  0.08 93.37 <0.001
Weight,kg 117.9 22.4 97.2 18.5 52.27 <0.001
Age,years  51.4 13.8 46.8 14.4 14.66 <0.001
Weightchange,kg  –5.8  4.9 –3.8  3.5 –33.28 <0.001
Percentweightchange  –4.9  4.0 –3.9  3.5 –14.65 <0.001
Weeksattended   9.2  3.6  8.8  3.5 0.78 0.438
StartBMI,kg/m2  37.8  6.6 36.7  6.5 8.88 <0.001
EndBMI,kg/m2  36.0  6.5 35.3  6.4 5.85 <0.001





Estimate Standarderror t(n=34,184) p-value
Constant  1.285 0.353    3.64 <0.001
Age,years –0.006 0.001   –6.12 <0.001
Height,m  0.149 0.199    0.75 0.453
Gender,male –0.612 0.053  –11.61 <0.001
StartBMI,kg/m2  0.008 0.002    3.92 <0.001
Attendances –0.438 0.004 –108.55 <0.001








benefit of resource, infrastructure, and scale,whichenables
them tooffer the regular support that isdifficult toachieve
within current NHS resources. However, there is a lack of
consensus,duetoalackofevidence,astohoweffectivecom-
mercialpartnerships are.Acomprehensive reviewofmajor
commercial weight loss programmes in the US noted that
there needs to bemore evidence to support the use of the
majorcommercialandself-helpprogrammes[21].Sincethen
evidence isemergingas tohoweffectivecommercialbehav-
iour change programmes can be in helping people control
theirweight[14,22–26].Thepresentdatasetprovidesimpor-
tantcomponentsoftheauditevidencebasefortheUK.
Rate and Extent of Weight Loss
Thecurrentauditisthelargestexaminationoftheimpactof
referral to commercial weight management support con-
ductedintheUKtodate.Theresultsaresimilartoourinitial
feasibilitytrialofthisscheme[14].58.1%oftheauditpopu-
lation completed at least 10 of the 12 sessions of the pro-
gramme,which issimilartopreviousworkbyourselves[14]
andothers[25].35.8%ofthiswholepopulationand54.7%of
31.3%anddecreased thepercentof thevariancedue toat-
tendance to 17.3%.Thosewho lostmoreweight inweek 1
tendedtoattendlonger.Bothcumulativestepwiseregression
models explained the similar total amounts of variance in
percentweightlost.
Discussion
Weightmanagement treatment inprimarycare isan impor-
tantfirststageofanysteppedcaremodelforweightcontrol
[4].Reductions in at least 5%baselineweight can improve







as onemeans of expanding provision of obesity services in
primary care [3, 4, 13]. Commercial organisations have the
Change Degreesoffreedom %variance F-ratio p-value
Age,years 1  1.3 859.21 <0.001
Height,m 1  0.3 167.07 <0.001
Gender 1  0.3 233.55 <0.001
StartBMI,kg/m2 1  0.0 0.11 0.743
Attendances,weeks 1 29.6 20,202.28 <0.001












lossesof 11.3%havebeen seen for those still attending the
group [14] andalso11.4% in24 sessions (approximately 24
weeks)inself-referredmalemembersoftheCWMO[22].We
arecurrentlydeveloping further trials,with longer-term fol-
low-upasanimportantadjuncttothepresentaudit.
Thepresentresultsshowameanweightlossof4.0%(5.5%
for completers) in 12 sessions.Thesedata comparevery fa-
vourably topharmacological treatments forobesity [29–31].
Recentreviewsandmeta-analysessuggestthatobesitydrugs
donotproducemore than5%weight lossonaverage in12




avery favourablecost compared to theequivalentprescrip-
tion costs forobesitydrugs,which cost approximatelyGBP
1.00perdayonanetbasisaccordingtotheBritishNational
Formulary 2009 [32]. Even if we assume that both referral
schemesanddrugsproducedthesameweightlossin3months
thereferralschemewouldcostGBP47.39forabout12weeks
compared to about GBP 84.00 for the net cost of obesity
drugs. It can therefore be reasonably concluded that NHS
referralschemesforweightlossareacost-effectiveoption.
Prediction of Weight Loss
Thepercentofweightlostwasnotstronglyrelatedtoinitial
bodyweightandsothosewithmoreweighttolosedidnot
achieve a greater percent weight loss. However, percent
weightlostinthefirstweekwasalmostasgreatapredictor
ofpercentweight loss at theendof the referralperiodas
was attendance throughout the referralperiod.Thiseffect




in the first week aremoremotivated (either before they
attendorasaconsequenceoftheirexperiencesinthefirst
week), so theymayhave familiarised themselveswith the
eatingandactivityprogrammetoagreaterextentandare
simplyonaconsistenttrajectoryofgreaterweightlossora
combination of these variables. We have previously ob-
served inourcommercialweightmanagementgroups that
thosewho losemostweight in the firstweekdogoon to
losemoreweight [33].Exactlyhow this relates tomotiva-
tion and the prevention of lapses and relapses warrants
furtherdetailedinvestigation[7–9].
50.1%ofthevarianceinweightlosswasnotexplainedby
the simple predictive model, suggesting that much of the
variabilityonweightlossisduetootherpsychological,behav-
ioural,orevenphysiologicaltraitsofdifferentindividualspar-
ticipating in the scheme.Weare currently analysing studies
collecting psychological and behavioural determinants of
longer-termweightlosssuccess.
thecompleterslostatleast5%oftheirbodyweightinabout
3 months, which is the current recommended initial target
weight loss (within 3–6 months), according to the NICE
guidelinesandtheDepartmentofHealth[4,13].92.1%ofall
participants lostweightor remainedweight stable ifweuse
the assumptions of the Last Observation Carried Forward
Model[15].Itispossiblethatsomeofthosewhodroppedout
early gainedmoreweight during the 12-session referral pe-
riod. Nevertheless, these data are encouraging from a pre-













non-completers. The trajectory of weight loss for the com-
pleterandnon-completergroupsiscurvilinear,whichistypi-
cal for obesity treatments in general [21, 27]. Weight loss
beginsrapidlyandstartstoslowasweightlossproceeds.Itis












men compared to women, although men did not attend a





Comparison with Other Approaches to Weight Management
People treated with a comprehensive group behavioural
approach lose approximately 9% of initial weight in 20–26
weeksof treatment [21].Although thepresentdataset only
gives a timewindow of approximately 3months, results of






the initial referral period is limited to about 12 weeks, the
partnership opens the door to long-term weight control
throughself-referralorcontinuedNHSreferral.Finally,these
datahaveconfirmed that thereare twosimplebasicpredic-
tors(attendanceandweightlossinthefirstweek)ofweight











land, for conductingan independent statisticalanalysisof thedata.We
wouldliketothanktheSlimmingWorldonReferralteamforentryofthe





Strengths and Limitations of the Study
As thiswasa serviceaudit, limitations to this study include
theabsenceofacontrolgroupandthefactthatresultswere
baseduponthosepeoplewhojoinedagroup,ratherthanin-
tention to treat. There were no comparable and consistent




















demonstrated that partnership working for weight mana-
gement is effective,benefitspatients, and (aspreviously re-
ported[14])canbelessexpensivethanotherin-houseoptions
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